{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:45:21Z","timestamp":1761630321912},"reference-count":140,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T00:00:00Z","timestamp":1221782400000},"content-version":"vor","delay-in-days":1784,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Cutaneous lymphomas are rare and, although some are a manifestation of systemic lymphoma, the majority arise primarily from the skin. These primary cutaneous lymphomas comprise both T\u2010 and B\u2010cell subtypes and represent a wide spectrum of disorders, which at times can be difficult to diagnose and classify. Classical therapeutic strategies include topical corticosteroids, phototherapy, radiotherapy, retinoids, extracorporeal photopheresis, topical chemotherapy, systemic chemotherapy and biological response modifiers. Newer therapies include the synthetic retinoid bexarotene, the immunotoxin conjugate denileukin diftitox, interleukin\u201012 and monoclonal antibodies such as alemtuzumab and rituximab.<\/jats:p>","DOI":"10.1046\/j.1440-0960.2003..x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:02:25Z","timestamp":1068768145000},"page":"227-242","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Management of the primary cutaneous lymphomas"],"prefix":"10.1111","volume":"44","author":[{"given":"H Miles","family":"Prince","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,9,19]]},"reference":[{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.15.2908"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1997.tb01018.x"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.10.2152"},{"key":"e_1_2_13_5_2","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and S\u00e9zary syndrome","volume":"88","author":"Diamandidou E","year":"1996","journal-title":"Blood"},{"issue":"1","key":"e_1_2_13_6_2","first-page":"S13","article-title":"The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms","volume":"111","author":"Frizzera G","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199707000-00001"},{"key":"e_1_2_13_8_2","first-page":"498","article-title":"How useful are T\u2010cell receptor gene rearrangement studies as an adjunct to the histopathologic diagnosis of mycosis fungoides?","volume":"21","author":"Bergman R","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/00313020120105615"},{"key":"e_1_2_13_10_2","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe ES","year":"2001"},{"key":"e_1_2_13_11_2","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: A proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_13_12_2","first-page":"725","article-title":"Report of the Committee on Staging and Classification of Cutaneous T\u2010Cell Lymphomas","volume":"63","author":"Bunn PA","year":"1979","journal-title":"Cancer Treat. Report"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70491-3"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912283212603"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.4.1150"},{"key":"e_1_2_13_16_2","first-page":"2212","article-title":"Transformation of mycosis fungoides: Clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas","volume":"95","author":"Vergier B","year":"2000","journal-title":"Blood"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.9c119.x"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008397323199"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.01680090075007"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.8.949"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90241-4"},{"key":"e_1_2_13_22_2","first-page":"802","article-title":"Mycosis fungoides: Management with topical nitrogen mustard","volume":"22","author":"Hoppe RT","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000429580"},{"key":"e_1_2_13_24_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2340\/00015555614751","article-title":"Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: A report from the Scandanavian Mycosis Fungoides Study Group","volume":"61","author":"Molin L","year":"1980","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1978.tb01517.x"},{"key":"e_1_2_13_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02928.x"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198405033101805"},{"key":"e_1_2_13_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704103361501"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70405-6"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.11.1377"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120911"},{"key":"e_1_2_13_32_2","first-page":"809","article-title":"Low dose interferon\u2010alpha 2b combined with PUVA is an effective treatment of early stage mycosis fungoides: Results of a multicenter study","volume":"84","author":"Rupoli S","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_13_33_2","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon alpha\u20102a plus acitretin versus interferon alpha\u20102a plus PUVA in patients with cutaneous T\u2010cell lymphoma stages I and II","volume":"92","author":"Stadler R","year":"1998","journal-title":"Blood"},{"key":"e_1_2_13_34_2","first-page":"536","article-title":"Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group","volume":"69","author":"Thomsen K","year":"1989","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_13_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00127-2"},{"key":"e_1_2_13_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831215)52:12<2214::AID-CNCR2820521207>3.0.CO;2-H"},{"key":"e_1_2_13_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)90103-1"},{"key":"e_1_2_13_38_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841868109130423"},{"key":"e_1_2_13_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0147-0272(90)90018-L"},{"key":"e_1_2_13_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00553-1"},{"key":"e_1_2_13_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1912::AID-CNCR23>3.0.CO;2-1"},{"key":"e_1_2_13_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)90102-3"},{"key":"e_1_2_13_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30058-3"},{"key":"e_1_2_13_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(86)90361-5"},{"key":"e_1_2_13_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90252-Q"},{"key":"e_1_2_13_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(90)90075-U"},{"key":"e_1_2_13_47_2","first-page":"73","article-title":"Rotational total skin electron beam therapy","volume":"164","author":"Kumar PP","year":"1988","journal-title":"Strahlenther. Onkol."},{"key":"e_1_2_13_48_2","first-page":"51","article-title":"Dosimetry of rotational versus multifield total\u2010skin electron\u2010beam therapy","volume":"5","author":"Kumar PP","year":"1987","journal-title":"Radiat. Med."},{"key":"e_1_2_13_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198708000-00018"},{"key":"e_1_2_13_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199204000-00005"},{"key":"e_1_2_13_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<1985::AID-CNCR16>3.0.CO;2-O"},{"key":"e_1_2_13_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.1.26"},{"key":"e_1_2_13_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(83)90321-8"},{"key":"e_1_2_13_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70142-3"},{"key":"e_1_2_13_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00517-3"},{"key":"e_1_2_13_56_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.2.923"},{"key":"e_1_2_13_57_2","first-page":"536","article-title":"Retinoids plus PUVA and PUVA in mycosis fungoides, plaque stage. A report form the Scandanavian Mycosis Fungoides Group","volume":"69","author":"Thomsen K","year":"1989","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_13_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70036-2"},{"key":"e_1_2_13_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90282-0"},{"key":"e_1_2_13_60_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2340\/0001555562162164","article-title":"Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis fungoides","volume":"62","author":"Zachariae H","year":"1982","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_13_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90717-1"},{"key":"e_1_2_13_62_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinte.1987.00370030133026","article-title":"The effect of isotretinoin in six patients with cutaneous T\u2010cell lymphoma","volume":"147","author":"Neely SM","year":"1987","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_13_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1987.01660260071016"},{"key":"e_1_2_13_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1986.tb01961.x"},{"key":"e_1_2_13_65_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2340\/0001555567232236","article-title":"Oral retinoids in mycosis fungoides and Sezary syndrome: A comparson of isotretinoin and etretinate","volume":"67","author":"Molin L","year":"1987","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_13_66_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/0001555564563566","article-title":"13\u2010cis\u2010retinoic acid effective in mycosis fungoides. A report from the Scandanavian Mycosis Fungoides Group","volume":"64","author":"Thomsen K","year":"1984","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_13_67_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archderm.1987.01660260071016","article-title":"Isotretinoin and cutaneous T cell lymphoma","volume":"123","author":"Kessler JF","year":"1987","journal-title":"Arch. Dermatol."},{"key":"e_1_2_13_68_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.790"},{"key":"e_1_2_13_69_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00044a014"},{"key":"e_1_2_13_70_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2001.00488.x"},{"key":"e_1_2_13_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860415)57:8 <1689::AID-CNCR2820571311>3.0.CO;2-M"},{"key":"e_1_2_13_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70049-9"},{"key":"e_1_2_13_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.8.1001"},{"key":"e_1_2_13_74_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.10.1359"},{"key":"e_1_2_13_75_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2340\/0001555574333","article-title":"Mycosis fungoides and allogeneic bone marrow transplantation","volume":"74","author":"Koeppel M\u2010C","year":"1994","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_13_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12875523"},{"key":"e_1_2_13_77_2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0889-8588(18)30061-3","article-title":"Chemotherapy for mycosis fungoides and the S\u00e9zary syndrome","volume":"5","author":"Rosen ST","year":"1995","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"e_1_2_13_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90007-0"},{"key":"e_1_2_13_79_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109857"},{"key":"e_1_2_13_80_2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood.V87.3.906.bloodjournal873906","article-title":"Phase II trial of 2\u2010chlordeoxyadenosine for the treatment of cutaneous T\u2010cell lymphoma","volume":"87","author":"Kuzel TM","year":"1996","journal-title":"Blood"},{"key":"e_1_2_13_81_2","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1200\/JCO.1994.12.12.2588","article-title":"The role of pentostatin in the treatment of T\u2010cell malignancies: Analysis of response rate in 145 patients according to disease subtype","volume":"12","author":"Matutes ME","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_13_82_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2603"},{"key":"e_1_2_13_83_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.376"},{"key":"e_1_2_13_84_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2456"},{"key":"e_1_2_13_85_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1622"},{"key":"e_1_2_13_86_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.902.415k23_902_908"},{"key":"e_1_2_13_87_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2802"},{"key":"e_1_2_13_88_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3257"},{"key":"e_1_2_13_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30052-2"},{"key":"e_1_2_13_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.3.841.841"},{"key":"e_1_2_13_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70054-L"},{"key":"e_1_2_13_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<70::AID-IJC12>3.0.CO;2-9"},{"key":"e_1_2_13_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499907"},{"key":"e_1_2_13_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12329711"},{"key":"e_1_2_13_95_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01773.x"},{"key":"e_1_2_13_96_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<304::AID-IJC3>3.0.CO;2-Z"},{"key":"e_1_2_13_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70212-X"},{"key":"e_1_2_13_98_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3602"},{"key":"e_1_2_13_99_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.108376"},{"key":"e_1_2_13_100_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051826"},{"key":"e_1_2_13_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702053160603"},{"key":"e_1_2_13_102_2","first-page":"629","article-title":"Photopheresis therapy of cutaneous T\u2010cell lymphoma: The Yale\u2010New Haven Hospital experience","volume":"62","author":"Heald PW","year":"1989","journal-title":"Yale J. Biol. Med."},{"key":"e_1_2_13_103_2","first-page":"567","article-title":"Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T\u2010cell lymphoma (CTCL)","volume":"102","author":"Koh HK","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"e_1_2_13_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90119-X"},{"key":"e_1_2_13_105_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.10.1347"},{"key":"e_1_2_13_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90683-0"},{"key":"e_1_2_13_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90118-8"},{"key":"e_1_2_13_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62067-3"},{"key":"e_1_2_13_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70597-3"},{"key":"e_1_2_13_110_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03286.x"},{"key":"e_1_2_13_111_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00830.x"},{"key":"e_1_2_13_112_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1298"},{"key":"e_1_2_13_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70045-1"},{"key":"e_1_2_13_114_2","first-page":"197","article-title":"Lymphomatoid papulosis: A follow\u2010up study of 41 patients","volume":"13","author":"Christensen HK","year":"1994","journal-title":"Semin. Dermatol."},{"key":"e_1_2_13_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70019-2"},{"key":"e_1_2_13_116_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2001.n.009"},{"key":"e_1_2_13_117_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3653"},{"key":"e_1_2_13_118_2","first-page":"1169","article-title":"Primary and secondary Ki\u20101+ (CD30+) anaplastic large cell lymphoma","volume":"135","author":"Kaudewitz P","year":"1989","journal-title":"Am. J. Pathol."},{"key":"e_1_2_13_119_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199905000-00012"},{"key":"e_1_2_13_120_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03472.x"},{"key":"e_1_2_13_121_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03490.x"},{"key":"e_1_2_13_122_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03527.x"},{"key":"e_1_2_13_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90219-8"},{"key":"e_1_2_13_124_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.70"},{"key":"e_1_2_13_125_2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V87.4.1207.bloodjournal8741207","article-title":"Classification of Natural Killer (NK) cell and NK\u2010like T\u2010cell malignancies","volume":"87","author":"Jaffe ES","year":"1996","journal-title":"Blood"},{"key":"e_1_2_13_126_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199807000-00010"},{"issue":"1","key":"e_1_2_13_127_2","first-page":"S84","article-title":"Approach to lymphoproliferative infiltrates of the skin","volume":"111","author":"Kempf W","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_2_13_128_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2001.n.014"},{"key":"e_1_2_13_129_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.398"},{"key":"e_1_2_13_130_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2471"},{"key":"e_1_2_13_131_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.549"},{"key":"e_1_2_13_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-0486(97)80009-9"},{"key":"e_1_2_13_133_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001015)89:8<1835::AID-CNCR26>3.0.CO;2-H"},{"issue":"1","key":"e_1_2_13_134_2","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/annonc\/11.suppl_1.S17","article-title":"Cutaneous lymphomas: A proposal for a unified approach to classification using the R.E.A.L.\/WHO classification","volume":"11","author":"Jaffe ES","year":"2000","journal-title":"Ann. Oncol."},{"key":"e_1_2_13_135_2","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B\u2010cell lymphomas: A European multicenter study","volume":"19","author":"Bekkenk MW","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_13_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1526-9655(11)70136-1"},{"key":"e_1_2_13_137_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008278725106"},{"key":"e_1_2_13_138_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199706000-00019"},{"key":"e_1_2_13_139_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199711000-00012"},{"key":"e_1_2_13_140_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.800"},{"key":"e_1_2_13_141_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199711000-00005"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-0960.2003..x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-0960.2003..x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:33:44Z","timestamp":1695857624000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-0960.2003..x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":140,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1046\/j.1440-0960.2003..x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-0960.2003..x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"2008-09-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}